A test including 53 genes can predict who will respond and who will not respond to triple negative breast cancer immunotherapy.
Breast Cancer Recurrence Screening Blood Test – Signatera
Most Patients With Triple Negative Breast Cancer Would Benefit From Genetic Testing
Can Immunotherapy be Democratized?
Triple-negative breast cancer Who should get tested for their genetic risk
Triple-negative breast cancer: Facts and stats
What is Breast Cancer? Symptoms, Risk Factors & Treatments
New Biomarker for Testicular Cancer-Related Autoimmune Disease
In Conversation with Rosalind Eeles
Recent advances in therapeutic strategies for triple-negative breast cancer, Journal of Hematology & Oncology